niacinamide has been researched along with Ewing Sarcoma in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In a study evaluating the combination of sorafenib, bevacizumab, and low-dose cyclophosphamide in children with solid tumors, an unexpectedly high incidence of pneumothorax was observed." | 3.81 | Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors. ( Davidoff, AM; Interiano, RB; McCarville, MB; Navid, F; Sandoval, J; Wu, J, 2015) |
| "Ewing sarcomas are rare mesenchymal-derived bone and soft tissue tumors in children." | 1.46 | ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand. ( Appert, A; Beauchamp, RD; Chung, DH; Lindsley, CW; Padmanabhan, C; Qiao, J; Rellinger, EJ; Waterson, AG, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giordano, G | 1 |
| Merlini, A | 1 |
| Ferrero, G | 1 |
| Mesiano, G | 1 |
| Fiorino, E | 1 |
| Brusco, S | 1 |
| Centomo, ML | 1 |
| Leuci, V | 1 |
| D'Ambrosio, L | 1 |
| Aglietta, M | 1 |
| Sangiolo, D | 1 |
| Grignani, G | 1 |
| Pignochino, Y | 1 |
| Rellinger, EJ | 1 |
| Padmanabhan, C | 1 |
| Qiao, J | 1 |
| Appert, A | 1 |
| Waterson, AG | 1 |
| Lindsley, CW | 1 |
| Beauchamp, RD | 1 |
| Chung, DH | 1 |
| Thompson, PA | 1 |
| Drissi, R | 1 |
| Muscal, JA | 1 |
| Panditharatna, E | 1 |
| Fouladi, M | 1 |
| Ingle, AM | 1 |
| Ahern, CH | 1 |
| Reid, JM | 1 |
| Lin, T | 1 |
| Weigel, BJ | 1 |
| Blaney, SM | 1 |
| Interiano, RB | 1 |
| McCarville, MB | 1 |
| Wu, J | 1 |
| Davidoff, AM | 1 |
| Sandoval, J | 1 |
| Navid, F | 1 |
1 trial available for niacinamide and Ewing Sarcoma
| Article | Year |
|---|---|
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).
Topics: Adolescent; Antineoplastic Agents; Area Under Curve; Bone Neoplasms; Child; Child, Preschool; Drug A | 2013 |
3 other studies available for niacinamide and Ewing Sarcoma
| Article | Year |
|---|---|
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Topics: Animals; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cell Line, Tumor; Chondrosarcoma; Comput | 2021 |
ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand.
Topics: Antigens, CD; Antineoplastic Agents; Apoptosis; Cadherins; Caspase 3; Cell Cycle; Cell Line, Tumor; | 2017 |
Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Bevacizumab; Bone Neoplasms; Child; Child, Preschool; Fe | 2015 |